2.4.2.30 0.0096 - N-[(2S)-1-hydroxybutan-2-yl]-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide pH and temperature not specified in the publication 736615 2.4.2.30 0.0111 - N-[(2S)-1-hydroxypropan-2-yl]-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide pH and temperature not specified in the publication 736615 2.4.2.30 0.0132 - N-[1-[4-(1H-imidazol-1-yl)phenyl]ethyl]-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide pH and temperature not specified in the publication 736615 2.4.2.30 0.086 - N-[2-oxo-4-(phenylamino)-3,8a-dihydro-2H-chromen-3-yl]acetamide 25°C, pH not specified in the publication 722786 2.4.2.30 0.031 - nicotinamide IC50: 0.031 mM 638001 2.4.2.30 0.21 - nicotinamide IC50: 0.21 mM 637997 2.4.2.30 4.7 - norharman IC50: 4.7 mM 637997 2.4.2.30 2.2 - novobiocin IC50: 2.2 mM, 5 mM, 90% inhibition in presence of Mg2+, 59% inhibition in absence of Mg2+ 637997 2.4.2.30 0.000925 - olaparib isoform ARDT7, pH and temperature not specified in the publication 736061 2.4.2.30 0.00204 - olaparib isoform ARDT10, pH and temperature not specified in the publication 736061